Android app Apple app link

Novocure seeks approval after pancreatic cancer wearable scores at Phase III

By Yahoo! Finance   |   3 weeks ago
Novocure seeks approval after pancreatic cancer wearable scores at Phase III

Novocure's Phase III PANOVA-3 study showed improved overall survival in pancreatic cancer patients treated with TTFields therapy alongside chemotherapy. Novocure plans to seek regulatory approval in key markets after positive results.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.